The lessons of Study 329: How fraud in psychiatric drug research got normalised
Study 329, which was a trial of paroxetine for depression in adolescents, is often held up as the poster child for fraud in clinical trials of psychiatric drugs. In Children of the cure: Missing data, lost lives and antidepressants, David Healy, Joanna Le Noury and Julie Wood painstakingly detail the entire sordid affair, including efforts to get the study retracted and to reanalyse the patient-level data. However, they do so with a larger purpose in mind. Study 329 is not presented as an aberration, but rather as emblematic of a systemic failure in modern medicine (or at least in psychiatry), which leads to prescribing practices that do great harm.